Clin Cancer Res 2006, 12:4055–4061.PubMedCrossRef 12. Wang X, Wang M, Amarzguioui M,

Liu F, Fodstad O, Prydz H: Downregulation of tissue factor by RNA interference in human melanoma LOX-L cells reduces pulmonary metastasis in nude mice. Int J Cancer 2004, 112:994–1002.PubMedCrossRef 13. Kim DH, Rossi JJ: Strategies for silencing human disease using RNA interference. Nat Rev Genet 2007, 8:173–184.PubMedCrossRef 14. Lu PY, Xie F, Woodle MC: In vivo application of RNA interference: from functional genomics to therapeutics. Adv Genet 2005, 54:117–142.PubMed 15. Holen T, Amarzguioui M, Wiiger MT, Babaie E, Prydz H: Positional effects selleck compound of short interfering RNAs targeting the human coagulation trigger

Tissue Factor. Nucleic Acids Res 2002, 30:1757–1766.PubMedCrossRef 16. Kruger NJ: The Bradford method for protein quantitation. Methods Mol Biol 1994, 32:9–15.PubMed 17. Fu WJ, Li JC, Wu XY, Yang ZB, Mo ZN, Huang JW, Xia GW, Ding Q, Liu KD, Zhu HG: Small interference RNA targeting Kruppel-like factor 8 inhibits the renal carcinoma 786–0 cells growth in vitro and in vivo. J Cancer Res Clin Oncol 2010, 136:1255–1265.PubMedCrossRef 18. Hou JQ, He J, Wang XL, Wen DG, Chen ZX: Effect of small interfering RNA targeting survivin gene on biological behaviour of bladder cancer. Chin Med J (Engl) 2006, 119:1734–1739. 19. Bradley SP, Kowalik TF, Rastellini C, DaCosta MA, Bloomenthal AB, Cicalese L, Basadonna GP, Uknis ME: Successful incorporation of short-interfering RNA into islet cells by in situ perfusion. SU5402 price STA-9090 mouse Transplant P 2005, 37:233–236.CrossRef 20. Toomey JR, Kratzer KE, Lasky NM, Broze GJ Jr: Effect

of tissue factor deficiency on mouse and tumor development. Proc Natl Farnesyltransferase Acad Sci USA 1997, 94:6922–6926.PubMedCrossRef 21. Versteeg HH, Schaffner F, Kerver M, Petersen HH, Ahamed J, Felding-Habermann B, Takada Y, Mueller BM, Ruf W: Inhibition of tissue factor signaling suppresses tumor growth. Blood 2008, 111:190–199.PubMedCrossRef 22. Rickles FR, Shoji M, Abe K: The role of the hemostatic system in tumor growth, metastasis, and angiogenesis: Tissue factor is a bifunctional molecule capable of inducing both fibrin deposition and angiogenesis in cancer. Int J Hematol 2001, 73:145–150.PubMedCrossRef 23. Chambers AF, Groom AC, MacDonald IC: Dissemination and growth of cancer cells in metastatic sites. Nature Reviews Cancer 2002, 2:563–572.PubMedCrossRef 24. Janssen-Heijnen ML, Coebergh JW: The changing epidemiology of lung cancer in Europe. Lung Cancer 2003, 41:245–258.PubMedCrossRef 25. Devesa SS, Bray F, Vizcaino AP, Parkin DM: International lung cancer trends by histologic type: male:female differences diminishing and adenocarcinoma rates rising. Int J Cancer 2005, 117:294–299.PubMedCrossRef 26.